US Stock MarketDetailed Quotes
DXCM DexCom
- 77.990
- -0.110-0.14%
Close Nov 29 13:00 ET
- 77.709
- -0.281-0.36%
Post 17:02 ET
30.46BMarket Cap47.27P/E (TTM)
79.370High77.890Low1.51MVolume78.400Open78.100Pre Close118.35MTurnover0.39%Turnover Ratio59.99P/E (Static)390.60MShares142.00052wk High15.39P/B30.22BFloat Cap62.34052wk Low--Dividend TTM387.46MShs Float164.863Historical High--Div YieldTTM1.90%Amplitude0.340Historical Low78.352Avg Price1Lot Size
About DexCom Company
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Company Profile
SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
MarketNASDAQ
Employees9600
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200
Websitehttp://www.dexcom.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 15.71M
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 4.34M
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 4.94M
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 4.25M
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 6.53M
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Karen M. Dahut
- Independent Director
- 345.90K
- Richard A. Collins
- Independent Director
- 345.90K
- Rimma Driscoll
- Independent Director
- 404.72K
- Nicholas Augustinos
- Independent Director
- 362.21K
- Kyle Malady
- Independent Director
- 343.40K
- Steven R. Altman
- Independent Director
- 343.40K
- Mark G. Foletta
- Lead Independent Director
- 393.51K
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 346.49K
- Bridgette P. Heller
- Independent Director
- 346.49K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
